Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 282-289 , March 2003

Cholesteryl ester transfer protein and lecithin: Cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: Associations with total and regional body fat

Received 8 January 2002 ,Accepted 24 September 2002.

References 

  1. Kannel WB, Hjortland MC, McNamara PM, et al.  Menopause and risk of cardiovascular disease: The Framingham study. Ann Intern Med. 1976;85:447–452
  2. National Center for Health Statistics . Health, United States, 1990. DHHS Pub. No. (PHS) 91-1232 Hyattsville, MD: Public Health Service; 1991;
  3. Rifkind BM. High-density lipoprotein cholesterol and coronary artery disease: Survey of the evidence. Am J Cardiol. 1990;66:3A–6A
  4. Gordon DJ, Probstfield JL, Garrison RJ, et al.  High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation. 1989;79:8–15
  5. Bonithon-Kopp C, Scarabin P-Y, Taquet A, et al.  Risk factors for early carotid atherosclerosis in middle-aged French women. Arteriosclerosis Thromb. 1991;11:966–972
  6. Frohlich JJ, Pritchard PH. The clinical significance of serum high density lipoproteins. Clin Biochem. 1989;22:417–423
  7. Tall AR. Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J Clin Invest. 1990;86:379–384
  8. Ginsberg HN. Lipoprotein physiology and its relationship to atherogenesis. Endocrinol Metab Clin North Am. 1990;19:211–228
  9. Davidson MH. Implications for the present and direction for the future. Am J Cardiol. 1993;71:32B–36B
  10. Mitchell BD, Stern MP, Haffner SM, et al.  Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites: The San Antonio Heart Study. Am J Epidemiol. 1990;131:423–433
  11. Stern MP, Rosenthal M, Haffner SM, et al.  Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: The San Antonio Heart Study. Am J Epidemiol. 1984;120:834–851
  12. Haffner SM, Stern MP, Hazuda HP, et al.  The role of behavioral variables and fat patterning in explaining ethnic differences in serum lipids and lipoproteins. Am J Epidemiol. 1986;123:830–839
  13. Greaves KA, Puhl J, Baranowski T, et al.  Ethnic differences in anthropometric characteristics of young children and their parents. Hum Biol. 1989;61:459–477
  14. Lapidus L, Bengtsson C, Larsson B, et al.  Distribution of adipose tissue and risk of cardiovascular disease and death: A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Br Med J. 1984;289:1257–1261
  15. Terry RB, Stefanick ML, Haskell WL, et al.  Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: Possible protective effects of thigh fat. Metabolism. 1991;40:733–740
  16. Rebuffe-Scrive M, Eldh J, Harfstrom L, et al.  Metabolism of mammary, abdominal and femoral adipocytes in women before and after menopause. Metabolism. 1986;9:792–797
  17. Soler JT, Folsom AR, Kushi LH, et al.  Association of body fat distribution with plasma lipids, lipoproteins, apolipoproteins A1 and B in postmenopausal women. J Clin Epidemiol. 1988;41:1075–1081
  18. Den Tonkelaar I, Seidell JC, Van Hoord PAH, et al.  Factors influencing waist/hip ratio in randomLy selected pre- and post-menopausal women in the Dom-Project (preliminary results). Int J Obesity. 1989;13:817–824
  19. Haarbo J, Marslew U, Gotfredsen A, et al.  Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 1991;40:1323–1326
  20. Cohen BB, Barbano HE, Cox CS. Plan and operation of the NHANES I Epidemiologic Follow-up Study, 1982-1984. DHHS publication (PHS) 87-1324. Vital Health Statistics. 1987;1:22
  21. Centers for Disease Control . Prevalence of overweight for Hispanics-United States, 1982-1984. MMWR. 1989;38:838–842
  22. Harrison GG, Buskirk ER, Carter JEL, et al.  Skinfold thicknesses and measurement technique. In:  Lohman TG,  Roche AF,  Martorell R editor. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Books; 1988;p. 55–70
  23. Svendsen OL, Hassanager C, Bergmann I, et al.  Measurement of abdominal and intra-abdominal fat in postmenopausal women by dual energy x-ray absorptiometry and anthropometry: Comparison with computed tomography. Int J Obesity. 1993;17:45–51
  24. Ortolà J, Castiñeiras MJ, Fuentes-Arderiu X. Biological variation data applied to the selection of serum lipid ratios used as risk markers of coronary heart disease. Clin Chem. 1992;38:56–59
  25. Bookstein L, Gidding SS, Donovan M, et al.  Day-to-day variability of serum cholesterol, triglycerides, and high density lipoprotein cholesterol levels. Arch Intern Med. 1990;150:1653–1657
  26. Deeg R, Ziegenhorn J. Kinetic enzymic method for automated determination of total cholesterol in serum. Clin Chem. 1983;29:1798–1802
  27. Warnic GR, Hguyen T, Albers AA. Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol. Clin Chem. 1985;31:217–222
  28. Kohlmeier M. Direct enzymic measurement of glycerides in serum and in lipoprotein fractions. Clin Chem. 1986;32:63–66
  29. Friedwald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  30. Puhl H, Waeg G, Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol. 1994;233:425–441
  31. Ogawa Y, Fielding CJ. Assay of cholesteryl ester transfer activity and purification of a cholesteryl ester transfer protein. Methods Enzymol. 1985;111:274–285
  32. Fielding CJ. Lecithin-cholesterol acyltransferase and cholesterol transport. Methods Enzymol. 1985;111:267–274
  33. Milliken LA, Greaves KA, Going SB, et al.  Reliability of dual-energy absorptiometry for measurement of abdominal soft tissue. Med Sci Sports Exerc. 1997;29:S37; (abstr)
  34. Davis RL, Lohman TG, Going SB, et al.  Cross calibration of DXA densitometer systems: Lunar vs. Hologic. Med Sci Sports Exerc. 1997;29:S37; (abstr)
  35. Quinet E, Tall A, Ramakrishnan R, et al.  Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest. 1991;87:1559–1566
  36. Mann CJ, Yen FT, Grant AM, et al.  Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest. 1991;88:2059–2066
  37. Lagrost L, Mensink RP, Guyard-Dangremont V, et al.  Variations in serum cholesteryl ester transfer and phospholipid transfer activitiers in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. Atherosclerosis. 1999;142:395–402
  38. Inazu A, Brown ML, Hesler CB, et al.  Increased high density lipoprotein caused by a common cholesteryl ester transfer protein gene mutation. N Engl J Med. 1990;323:1234–1238
  39. Cauley JA, Cummings SR, Black DM, et al.  Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 1990;163:1438–1444
  40. Quinet E, Agellon L, Marcel Y, et al.  Atherogenic diet increases cholesteryl ester transfer protein m RNA in rabbit liver. J Clin Invest. 1990;85:357–363
  41. Jiang X, Moulin P, Quinet E, et al.  Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem. 1991;266:4631–4639
  42. Arai T, Yamashita S, Hirano K, et al.  Increased plasma cholesteryl ester transfer protein in obese subjects: A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb. 1994;14:1129–1136
  43. Williams PT, Albers JJ, Krauss RM, et al.  Associations of lecithin:cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men. Atherosclerosis. 1990;82:53–58
  44. Haffner SM, Miettinen H, Stern MP, et al.  Plasma oxidizability in Mexican-Americans and non-Hispanic whites. Metabolism. 1996;45:878–881
  45. Krauss RM. Dense low density lipoproteins and coronary artery disease. Am J Cardiol. 1995;75:53B–57B
  46. Fusegawa Y, Kelley KL, Sawyer JK, et al.  Influence of dietary fatty acid composition on the relationship between CETP activity and plasma lipoproteins in monkeys. J Lipid Res. 2001;42:1849–1857
  47. Kamiyama S, Kim H-J, Furukawa Y. Inhibitory effects of oxidized low-density lipoprotein on the activity of plasma lecithin:cholesterol acyltransferase. Biosci Biotech Biochem. 1996;60:580–583
  48. Bielicki JK, Forte TM, McCall TM. Minimally oxidized LDL is a potent inhibitor of lecithin:cholesterol acyltransferase activity. J Lipid Res. 1996;37:1012–1021
  49. Sacks FM, McPherson R, Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med. 1994;154:1106–1110

☆ Supported in part by a grant from the Arizona Disease Control Research Commission, Phoenix, AZ (9511) and by NIH Grant No. AR39939. Part of the research upon which this publication is based was performed pursuant to Contract No. N01-WH-3-201115 with the NIH, DHHS.

☆☆ Address reprint requests to Kathryn A. Greaves, PhD, DuPont Protein Technologies, Nutritional Sciences, PO Box 88940, St Louis, MO 63188.

PII: S0026-0495(02)05261-7

doi: 10.1053/meta.2003.50045

Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 282-289 , March 2003

Article Tools